Literature DB >> 3004418

Guanine nucleotide regulation of agonist binding to muscarinic cholinergic receptors. Relation to efficacy of agonists for stimulation of phosphoinositide breakdown and Ca2+ mobilization.

T Evans, J R Hepler, S B Masters, J H Brown, T K Harden.   

Abstract

The efficacies of a series of six muscarinic cholinergic receptor agonists for stimulation of phosphoinositide breakdown and unidirectional efflux of 45Ca2+ in 1321N1 human astrocytoma cells were compared with the relative capacity of these agonists for formation of a GTP-sensitive high-affinity binding state in washed membranes. Carbachol and methacholine were 'full' agonists as regards phosphoinositide breakdown and Ca2+ mobilization, whereas bethanechol, arecoline and oxotremorine were 'partial' agonists for these two responses. Pilocarpine was the least efficacious of the six drugs tested. Except for pilocarpine, competition curves generated with the agonists and [3H]quinuclidinyl benzilate did not follow the Law of Mass Action for ligand interaction at a single site. Non-linear regression analyses of these data indicated that the data significantly better fit a two-, rather than a single-, site model with a high- and a low-affinity binding component. Competition curves generated in the presence of GTP were shifted to the right, and the extent of receptors in the high-affinity agonist-binding state was decreased. The relative efficacies of the six agonists for stimulation of phosphoinositide breakdown and Ca2+ mobilization were significantly correlated with the difference in affinities (KL/KH) between the two affinity states for each agonist. The relative efficacy of the agonists for stimulation of Ca2+ mobilization also was significantly correlated with the extent of receptors in the high-affinity state (%H) for each agonist. The results suggest that interaction with an as-yet unidentified guanine nucleotide regulatory protein is important in the mechanism whereby muscarinic receptors stimulate phosphoinositide breakdown in 1321N1 astrocytoma cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004418      PMCID: PMC1152947          DOI: 10.1042/bj2320751

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver.

Authors:  F MURAD; Y M CHI; T W RALL; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

2.  Receptor occupancy dose--response curve suggests that phosphatidyl-inositol breakdown may be intrinsic to the mechanism of the muscarinic cholinergic receptor.

Authors:  R H Michell; S S Jafferji; L M Jones
Journal:  FEBS Lett       Date:  1976-10-15       Impact factor: 4.124

3.  A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data.

Authors:  R S Kent; A De Lean; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

4.  GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

Review 5.  Molecular mechanisms of coupling in hormone receptor-adenylate cyclase systems.

Authors:  J M Stadel; A De Lean; R J Lefkowitz
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1982

6.  Excitation of Limulus photoreceptors by vanadate and by a hydrolysis-resistant analog of guanosine triphosphate.

Authors:  A Fein; D W Corson
Journal:  Science       Date:  1981-05-01       Impact factor: 47.728

7.  The binding of agonists to brain muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

Review 8.  Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines.

Authors:  J N Fain; J A García-Sáinz
Journal:  Life Sci       Date:  1980-04-14       Impact factor: 5.037

9.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

10.  Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells.

Authors:  H Matsuzawa; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  25 in total

1.  Central serotonin receptors: effector systems, physiological roles and regulation.

Authors:  P J Conn; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  Oligomerization of G protein-coupled receptors: past, present, and future.

Authors:  Paul S-H Park; Slawomir Filipek; James W Wells; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

3.  Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.

Authors:  M C Sekar; N Uemura; D H Coy; B I Hirschowitz; K E Dickinson
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

Review 4.  The role of G proteins in transmembrane signalling.

Authors:  C W Taylor
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

Review 5.  G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.

Authors:  Olivia M Yu; Joan Heller Brown
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

Review 6.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors.

Authors:  S B Freedman; E A Harley; L L Iversen
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

8.  Muscarinic regulation of cytosolic free calcium in canine tracheal smooth muscle cells: Ca2+ requirement for phospholipase C activation.

Authors:  C M Yang; S P Chou; Y Y Wang; J T Hsieh; R Ong
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 9.  Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.

Authors:  N T Burford; J R Traynor; A Alt
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

10.  Modulation of phosphatidylserine synthesis by a muscarinic receptor occupancy in human neuroblastoma cell line LA-N-1.

Authors:  I S Mikhaevitch; I N Singh; G Sorrentino; R Massarelli; J N Kanfer
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.